You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators

Article info

Article menu

Download PDFPDF

XML
Rheumatoid arthritis
Original research
How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators

Authors

  • Laurette van Boheemen Rheumatology, Reade, Amsterdam Rheumatology and Immunology Center, Amsterdam, North Holland, The Netherlands PubMed articlesGoogle scholar articles
  • Marieke M ter Wee Epidemiology and Data Science, Amsterdam Public Health, Amsterdam UMC Location VUmc, Amsterdam, The NetherlandsRheumatology and immunology, AI&I, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  • Bart Seppen Rheumatology, Reade, Amsterdam Rheumatology and Immunology Center, Amsterdam, North Holland, The Netherlands PubMed articlesGoogle scholar articles
  • Dirkjan van Schaardenburg Rheumatology, Reade, Amsterdam Rheumatology and Immunology Center, Amsterdam, North Holland, The NetherlandsRheumatology, Amsterdam UMC Location AMC, Amsterdam, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Laurette van Boheemen; l.vanboheemen{at}amsterdamumc.nl
View Full Text

Citation

van Boheemen L, ter Wee MM, Seppen B, et al
How to enhance recruitment of individuals at risk of rheumatoid arthritis into trials aimed at prevention: understanding the barriers and facilitators
RMD Open 2021;7:e001592. doi: 10.1136/rmdopen-2021-001592

Publication history

  • Received January 19, 2021
  • Revision received February 23, 2021
  • Accepted February 23, 2021
  • First published March 7, 2021.
Online issue publication 
March 07, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.